Annual Total Expenses
$972.57 M
-$981.04 M-50.22%
01 December 2023
Summary:
Sinovac Biotech annual total expenses is currently $972.57 million, with the most recent change of -$981.04 million (-50.22%) on 01 December 2023. During the last 3 years, it has risen by +$677.75 million (+229.89%). SVA annual total expenses is now -50.22% below its all-time high of $1.95 billion, reached on 31 December 2022.SVA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly total expenses is not available.SVA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +229.9% | - |
| 5 y5 years | +427.8% | - |
SVA Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -50.2% | +229.9% | ||
| 5 y | 5 years | -50.2% | +448.9% | ||
| alltime | all time | -50.2% | >+9999.0% |
Sinovac Biotech Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $972.57 M(-50.2%) | - |
| Dec 2022 | $1.95 B(+7.3%) | - |
| Dec 2021 | $1.82 B(+517.6%) | - |
| Dec 2020 | $294.82 M(+66.4%) | $130.42 M(+48.7%) |
| Sept 2020 | - | $87.68 M(+67.0%) |
| June 2020 | - | $52.50 M(+116.8%) |
| Mar 2020 | - | $24.22 M(-53.6%) |
| Dec 2019 | $177.20 M(-3.8%) | $52.24 M(+3.7%) |
| Sept 2019 | - | $50.40 M(+17.3%) |
| June 2019 | - | $42.98 M(+36.1%) |
| Mar 2019 | - | $31.58 M(-40.3%) |
| Dec 2018 | $184.26 M(+43.0%) | $52.93 M(+40.9%) |
| Sept 2018 | - | $37.56 M(-38.8%) |
| June 2018 | - | $61.34 M(+89.3%) |
| Mar 2018 | - | $32.40 M(+51.9%) |
| Dec 2017 | $128.89 M(+80.4%) | - |
| Dec 2016 | $71.45 M(+12.2%) | $21.33 M(-4.6%) |
| Sept 2016 | - | $22.36 M(+48.2%) |
| June 2016 | - | $15.09 M(+19.1%) |
| Mar 2016 | - | $12.67 M(-37.1%) |
| Dec 2015 | $63.69 M(+4.5%) | $20.15 M(+11.5%) |
| Sept 2015 | - | $18.08 M(+26.9%) |
| June 2015 | - | $14.24 M(+27.0%) |
| Mar 2015 | - | $11.22 M(-33.1%) |
| Dec 2014 | $60.97 M(-1.2%) | $16.78 M(+3.2%) |
| Sept 2014 | - | $16.25 M(+8.3%) |
| June 2014 | - | $15.01 M(+16.1%) |
| Mar 2014 | - | $12.93 M(-14.3%) |
| Dec 2013 | $61.74 M(-9.4%) | $15.10 M(-20.8%) |
| Sept 2013 | - | $19.07 M(+24.7%) |
| June 2013 | - | $15.29 M(+24.8%) |
| Mar 2013 | - | $12.26 M(-45.6%) |
| Dec 2012 | $68.18 M | $22.52 M(+19.5%) |
| Sept 2012 | - | $18.84 M(+48.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $12.66 M(-10.5%) |
| Mar 2012 | - | $14.15 M(-1.4%) |
| Dec 2011 | $53.01 M(+16.5%) | $14.35 M(-20.4%) |
| Sept 2011 | - | $18.02 M(+43.9%) |
| June 2011 | - | $12.53 M(+54.4%) |
| Mar 2011 | - | $8.11 M(-63.7%) |
| Dec 2010 | $45.52 M(+5.0%) | $22.37 M(+118.9%) |
| Sept 2010 | - | $10.22 M(+33.3%) |
| June 2010 | - | $7.67 M(+45.9%) |
| Mar 2010 | - | $5.26 M(-72.7%) |
| Dec 2009 | $43.34 M(+40.8%) | $19.27 M(+118.4%) |
| Sept 2009 | - | $8.82 M(-5.6%) |
| June 2009 | - | $9.34 M(+57.8%) |
| Mar 2009 | - | $5.92 M(-35.1%) |
| Dec 2008 | $30.79 M(+53.4%) | $9.13 M(+41.7%) |
| Sept 2008 | - | $6.44 M(-32.1%) |
| June 2008 | - | $9.49 M(+65.5%) |
| Mar 2008 | - | $5.73 M(-2.9%) |
| Dec 2007 | $20.07 M(+34.5%) | $5.91 M(-12.9%) |
| Sept 2007 | - | $6.79 M(+84.1%) |
| June 2007 | - | $3.69 M(+47.9%) |
| Dec 2006 | $14.91 M(+11.2%) | - |
| June 2006 | - | $2.49 M(-78.7%) |
| Dec 2005 | $13.41 M(+17.6%) | $11.70 M(+1247.9%) |
| Sept 2005 | - | $868.00 K(-71.9%) |
| June 2005 | - | $3.09 M(-2.9%) |
| Dec 2004 | $11.40 M(+238.5%) | $3.19 M(+10.9%) |
| Sept 2004 | - | $2.87 M(+7.5%) |
| June 2004 | - | $2.67 M(+78.5%) |
| Dec 2003 | $3.37 M(+410.5%) | $1.50 M(-34.3%) |
| Sept 2003 | - | $2.28 M |
| Apr 2002 | $659.80 K(-9.0%) | - |
| Apr 2001 | $725.30 K(+103.1%) | - |
| Apr 2000 | $357.10 K(+5393.8%) | - |
| Apr 1999 | $6500.00 | - |
FAQ
- What is Sinovac Biotech annual total expenses?
- What is the all time high annual total expenses for Sinovac Biotech?
- What is the all time high quarterly total expenses for Sinovac Biotech?
What is Sinovac Biotech annual total expenses?
The current annual total expenses of SVA is $972.57 M
What is the all time high annual total expenses for Sinovac Biotech?
Sinovac Biotech all-time high annual total expenses is $1.95 B
What is the all time high quarterly total expenses for Sinovac Biotech?
Sinovac Biotech all-time high quarterly total expenses is $130.42 M